文献速递脑血管病

卒中中的适应性平台试验

Adaptive Platform Trials in Stroke.
PubMed 文献 · Stroke · 2024-12-20

本文探讨适应性平台试验在卒中治疗研究中的设计、实施与统计学考量,指出传统双臂随机设计资源消耗大且证据生成慢,而平台试验可在单一基础设施内加速评估多种干预。文章重点介绍针对急性缺血性卒中的STEP试验和ACT-GLOBAL试验,二者采用多因素设计、贝叶斯建模等适应性特征,旨在最大化每位参与者提供的信息并加速有效疗法的识别。

要点

  • 传统双臂随机设计资源密集且证据生成慢,平台试验可在单一基础设施内加速多种治疗评估。
  • STEP试验和ACT-GLOBAL试验采用多因素设计、贝叶斯建模等适应性特征,同时回答多个治疗问题。
  • 平台试验旨在最大化每位参与者信息、贴近临床实践复杂性并加速有效疗法的识别。

核心结论

  • 适应性平台试验有望加速卒中新疗法、管理和康复措施的识别。

研究设计与样本

  • 本文为概念性文章,探讨适应性平台试验设计与实施中的概念、实践和统计学考量。
  • 文章重点介绍针对急性缺血性卒中的STEP试验(卒中网络取栓血管内平台试验)和ACT-GLOBAL试验(多因素、多臂、多阶段、随机、全球适应性平台试验)。

主要发现

  • 传统双臂随机设计每次仅评估一种干预,资源密集且减慢证据生成。
  • 平台试验基于主方案设计,允许多种干预进入和退出正在进行的平台。
  • STEP试验和ACT-GLOBAL试验采用多因素设计、贝叶斯建模及其他适应性特征,同时解决多个治疗问题。
  • 这些试验旨在最大化每位参与者获得的信息,并使临床研究更贴近临床诊疗的复杂性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clinical trials of treatments for stroke have generally utilized 2-arm, randomized designs to evaluate a single intervention against a control. Running separate clinical trials, with each addressing a single therapeutic question, is resource intensive and slows evidence generation, especially in a field with rapidly expanding treatment options and evolving practices. Platform trials-randomized clinical trials designed to evaluate multiple interventions that may enter and exit the ongoing platform based on a master protocol-accelerate the investigation of multiple therapeutic options within a single infrastructure. This in turn has the potential to accelerate access to new interventions for patients with stroke that can save lives and improve outcomes. In the context of acute ischemic stroke, 2 new platform trials have been established, the STEP trial (StrokeNet Thrombectomy Endovascular Platform) and ACT-GLOBAL (A Multi-Factorial, Multi-Arm, Multi-Stage, Randomised, Global Adaptive Platform Trial for Stroke), to address multiple therapeutic questions simultaneously using a multifactorial design including Bayesian modeling and other adaptive features. These trials are designed to maximize the information obtained from each participant, to align clinical research more closely with the complexities of clinical care, and to accelerate the identification of effective therapies. This article explores conceptual, practical, and statistical considerations in the design and implementation of adaptive platform trials and highlights their potential to accelerate the identification of new therapies, management, and rehabilitation in stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Lorenzi E, Crawford AM, Anderson CS, et al. Adaptive Platform Trials in Stroke. Stroke. 2024. PMID: 39705391. doi:10.1161/STROKEAHA.124.045754

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。